Skip to content
10-Q

Quarterly Report

NeuBase Therapeutics, Inc.

0001558370-23-018577

← back to feed
Filed
Nov 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 6, 2023 3.73M sh
Shares Diluted Q3 2023 · Sep 30, 2023 2.76M sh
Shares Diluted Q3 2023 · Sep 30, 2023 2.05M sh
Shares Diluted Q3 2023 · Sep 30, 2022 1.61M sh
Shares Diluted Q3 2023 · Sep 30, 2022 1.62M sh
Capex Q3 2023 · Sep 30, 2023 $13.45K
Capex Q3 2023 · Sep 30, 2022 $347.84K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$9.09M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$23.74M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $12.57M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $17.39M
Stockholders Equity Q3 2023 · Sep 30, 2023 $9.14M
Stockholders Equity Q3 2023 · Jun 30, 2023 $11.25M
Stockholders Equity Q3 2023 · Mar 31, 2023 $14.45M
Stockholders Equity Q3 2023 · Dec 31, 2022 $18.22M
Stockholders Equity Q3 2023 · Sep 30, 2022 $23.19M
Stockholders Equity Q3 2023 · Jun 30, 2022 $30.31M
Stockholders Equity Q3 2023 · Mar 31, 2022 $38.16M
Stockholders Equity Q3 2023 · Dec 31, 2021 $47.13M
Current Liabilities Q3 2023 · Sep 30, 2023 $4.65M
Current Liabilities Q3 2023 · Dec 31, 2022 $2.15M
Total Liabilities Q3 2023 · Sep 30, 2023 $9.48M
Total Liabilities Q3 2023 · Dec 31, 2022 $7.36M
Current Assets Q3 2023 · Sep 30, 2023 $13.35M
Current Assets Q3 2023 · Dec 31, 2022 $17.97M
Total Assets Q3 2023 · Sep 30, 2023 $18.62M
Total Assets Q3 2023 · Dec 31, 2022 $25.58M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.66
Eps Diluted Q3 2023 · Sep 30, 2023 −$4.57
Eps Diluted Q3 2023 · Sep 30, 2022 −$4.73
Eps Diluted Q3 2023 · Sep 30, 2022 −$16.08
Eps Basic Q3 2023 · Sep 30, 2023 −$0.66
Eps Basic Q3 2023 · Sep 30, 2023 −$4.57
Eps Basic Q3 2023 · Sep 30, 2022 −$4.73
Eps Basic Q3 2023 · Sep 30, 2022 −$16.08
Sga Expense Q3 2023 · Sep 30, 2023 $1.2M
Sga Expense Q3 2023 · Sep 30, 2023 $6.52M
Sga Expense Q3 2023 · Sep 30, 2022 $2.24M
Sga Expense Q3 2023 · Sep 30, 2022 $8.93M
Rd Expense Q3 2023 · Sep 30, 2023 $387.56K
Rd Expense Q3 2023 · Sep 30, 2023 $2.91M
Rd Expense Q3 2023 · Sep 30, 2022 $5.49M
Rd Expense Q3 2023 · Sep 30, 2022 $17.08M
Net Income Q3 2023 · Sep 30, 2023 −$1.82M
Net Income Q3 2023 · Sep 30, 2023 −$9.36M
Net Income Q3 2023 · Jun 30, 2023 −$3.45M
Net Income Q3 2023 · Mar 31, 2023 −$4.09M
Net Income Q3 2023 · Sep 30, 2022 −$7.63M
Net Income Q3 2023 · Sep 30, 2022 −$26.05M
Net Income Q3 2023 · Jun 30, 2022 −$8.49M
Net Income Q3 2023 · Mar 31, 2022 −$9.92M
Operating Income Q3 2023 · Sep 30, 2023 −$2.81M
Operating Income Q3 2023 · Sep 30, 2023 −$10.67M
Operating Income Q3 2023 · Sep 30, 2022 −$7.72M
Operating Income Q3 2023 · Sep 30, 2022 −$26.01M